Trade Summary

2 days ago, Sabba Stephen L, serving as Dir at Ligand Pharmaceuticals Inc (LGND), sold 2,034 shares at $201.50 per share, for a total transaction value of $409,851.00. Following this transaction, Sabba Stephen L now holds 33,793 shares of LGND.

This sale represents a 6.00% decrease in Sabba Stephen L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Ligand Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.